Renephra Limited - Period Ending 2022-03-31

Renephra Limited - Period Ending 2022-03-31


Renephra Limited 06815501 false 2021-04-01 2022-03-31 2022-03-31 The principal activity of the company is medical research Digita Accounts Production Advanced 6.30.9574.0 true 06815501 2021-04-01 2022-03-31 06815501 2022-03-31 06815501 core:RetainedEarningsAccumulatedLosses 2022-03-31 06815501 core:ShareCapital 2022-03-31 06815501 core:SharePremium 2022-03-31 06815501 core:CurrentFinancialInstruments 2022-03-31 06815501 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 06815501 core:FurnitureFittingsToolsEquipment 2022-03-31 06815501 bus:SmallEntities 2021-04-01 2022-03-31 06815501 bus:AuditExemptWithAccountantsReport 2021-04-01 2022-03-31 06815501 bus:AbridgedAccounts 2021-04-01 2022-03-31 06815501 bus:SmallCompaniesRegimeForAccounts 2021-04-01 2022-03-31 06815501 bus:RegisteredOffice 2021-04-01 2022-03-31 06815501 bus:Director2 2021-04-01 2022-03-31 06815501 bus:Director8 2021-04-01 2022-03-31 06815501 bus:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 06815501 core:Goodwill 2021-04-01 2022-03-31 06815501 core:PatentsTrademarksLicencesConcessionsSimilar 2021-04-01 2022-03-31 06815501 core:ComputerEquipment 2021-04-01 2022-03-31 06815501 core:FurnitureFittingsToolsEquipment 2021-04-01 2022-03-31 06815501 6 2021-04-01 2022-03-31 06815501 countries:EnglandWales 2021-04-01 2022-03-31 06815501 2021-03-31 06815501 core:FurnitureFittingsToolsEquipment 2021-03-31 06815501 2020-04-01 2021-03-31 06815501 2021-03-31 06815501 core:RetainedEarningsAccumulatedLosses 2021-03-31 06815501 core:ShareCapital 2021-03-31 06815501 core:SharePremium 2021-03-31 06815501 core:CurrentFinancialInstruments 2021-03-31 06815501 core:CurrentFinancialInstruments core:WithinOneYear 2021-03-31 06815501 core:FurnitureFittingsToolsEquipment 2021-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 06815501

Renephra Limited

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 March 2022

 

Renephra Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 9

 

Renephra Limited

Company Information

Directors

Dr Idalia Lucja Dawidowska

Dr Joanne Phoenix

Registered office

Medtech Centre Greenheys
Manchester Science Park
Pencroft Way
Manchester
M15 6JJ

 

Renephra Limited

(Registration number: 06815501)
Abridged Balance Sheet as at 31 March 2022

Note

2022
£

2021
£

Fixed assets

 

Intangible assets

4

1,626,614

1,591,668

Tangible assets

5

360

592

 

1,626,974

1,592,260

Current assets

 

Debtors

6

930

26,242

Cash at bank and in hand

 

1,909

20,460

 

2,839

46,702

Prepayments and accrued income

 

3,780

24,366

Creditors: Amounts falling due within one year

(2,015)

(1,715)

Net current assets

 

4,604

69,353

Total assets less current liabilities

 

1,631,578

1,661,613

Accruals and deferred income

 

-

(13,058)

Net assets

 

1,631,578

1,648,555

Capital and reserves

 

Called up share capital

7

6,003

6,003

Share premium reserve

2,682,913

2,682,913

Retained earnings

(1,057,338)

(1,040,361)

Shareholders' funds

 

1,631,578

1,648,555

For the financial year ending 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

 

Renephra Limited

(Registration number: 06815501)
Abridged Balance Sheet as at 31 March 2022

Approved and authorised by the Board on 20 September 2022 and signed on its behalf by:
 

.........................................
Dr Idalia Lucja Dawidowska
Director

 

Renephra Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2022

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Medtech Centre Greenheys
Manchester Science Park
Pencroft Way
Manchester
M15 6JJ

These financial statements were authorised for issue by the Board on 20 September 2022.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Other grants

Grants are recognised in the financial statements when there has been reasonable assurance that a) the entity will comply with the conditions attaching to the grant; and b) the grants will be received.

The grants are recognised under the performance model, where a grant does not impose specified future performance-related conditions on the recipient is recognised in income when the grant proceeds are received or receivable.

Grants have been recognised in the entity's financial statements at the fair value of the asset received or receivable.

 

Renephra Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2022

Tax

The tax expense for the period comprises tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Computer equipment

33.3% Reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.

Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.

Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

 

Renephra Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2022

Development costs

Intangible assets arising from development (or from the development phase of
an internal project) have been recognised if, and only if, an entity can demonstrate all of the following:
a) The technical feasibility of completing the intangible asset so that it will be available for use or sale.
b) Its intention to complete the intangible asset and use or sell it.
c) Its ability to use or sell the intangible asset.
d) How the intangible asset will generate probable future economic benefits. Among other things, the
entity can demonstrate the existence of a market for the output of the intangible asset or the
intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.
e) The availability of adequate technical, financial and other resources to complete the development and
to use or sell the intangible asset.
f) Its ability to measure reliably the expenditure attributable to the intangible asset during its
development.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

At cost, with impairment reviewed

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Renephra Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2022

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 1 (2021 - 1).

 

Renephra Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2022

4

Intangible assets

Total
£

Cost or valuation

At 1 April 2021

1,591,668

Additions acquired separately

34,946

At 31 March 2022

1,626,614

Amortisation

Carrying amount

At 31 March 2022

1,626,614

At 31 March 2021

1,591,668

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2021

2,274

2,274

At 31 March 2022

2,274

2,274

Depreciation

At 1 April 2021

1,682

1,682

Charge for the year

232

232

At 31 March 2022

1,914

1,914

Carrying amount

At 31 March 2022

360

360

At 31 March 2021

592

592

6

Debtors

Debtors includes £Nil (2021 - £Nil) due after more than one year.

7

Share capital

Allotted, called up and fully paid shares

 

Renephra Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2022

 

2022

2021

 

No.

£

No.

£

Ordinary of £0.01 each

600,319

6,003

600,319

6,003

Ordinary A of £0.01 each

-

-

-

-

Ordinary B of £0.01 each

-

-

-

-

 

600,319

6,003

600,319

6,003